William Annett
Finanzdirektor/CFO bei Sustained Therapeutics, Inc.
Profil
William Annett is the founder of Corra Life Sciences, Inc. which was founded in 2001.
He was the Chief Executive Officer from 2001 to 2003.
Currently, he holds three positions: Director at California Biomedical Innovation Alliance since 2015, Director at Imagia Canexia Health since 2022, and President & Chief Financial Officer at Sustained Therapeutics, Inc. since 2022.
Mr. Annett's former positions include Chief Executive Officer at BioFX Laboratories, Inc., Managing Director at Accenture LLC from 2011 to 2014, Director at OncoCyte Corp.
in 2015, and Principal at Lineage Cell Therapeutics, Inc. Mr. Annett holds an MBA degree from Harvard Business School.
Aktive Positionen von William Annett
| Unternehmen | Position | Beginn |
|---|---|---|
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe. | Direktor/Vorstandsmitglied | 23.11.2015 |
Imagia Canexia Health
 Imagia Canexia Health Packaged SoftwareTechnology Services Imagia Canexia Health is a genomics-based cancer treatment testing Canadian company that combines AI expertise with advanced molecular biopsy solutions. The private company is located in Canada. The company provides oncologists with AI-based informatics for treatment selection and monitoring, allowing for leading clinical decision support. With a network of over 20 hospitals and reference labs worldwide, they aim to ensure that doctors have the necessary insights to deliver cost-effective cancer testing to patients regardless of where they seek treatment. The CEO of the company is James Lumsdaine. | Direktor/Vorstandsmitglied | 22.09.2022 |
Sustained Therapeutics, Inc.
 Sustained Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Sustained Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in an undisclosed location. Sustained Therapeutics is developing a sustained-release drug delivery platform for managing acute and chronic pain. The Canadian company is currently conducting clinical trials for ST-01, their innovative sustained-release form of Lidocaine, for various pain indications. Patients can join their trials to experience the benefits of sustained-release Lidocaine today. The company was founded by Martin E. Gleave. | Finanzdirektor/CFO | 22.09.2022 |
Ehemalige bekannte Positionen von William Annett
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOCYTE CORPORATION | Vorstandsvorsitzender | 01.07.2019 |
Accenture LLC
 Accenture LLC Miscellaneous Commercial ServicesCommercial Services Accenture LLC operates as a global management consulting, technology services and outsourcing company. The company is headquartered in Reston, VA. | Vorstandsvorsitzender | 01.01.2014 |
| Corra Life Sciences, Inc. | Vorstandsvorsitzender | 01.01.2003 |
| LINEAGE CELL THERAPEUTICS, INC. | Corporate Officer/Principal | - |
BioFX Laboratories, Inc.
 BioFX Laboratories, Inc. BiotechnologyHealth Technology BioFX Laboratories, Inc. develops and supplies reagents for the biomedical research market. The company was founded by Steve Mefferd &. Thomas M. Woerner in 1997 and is headquartered in Owings Mills, MD | Vorstandsvorsitzender | - |
Ausbildung von William Annett
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
BioFX Laboratories, Inc.
BioFX Laboratories, Inc. BiotechnologyHealth Technology BioFX Laboratories, Inc. develops and supplies reagents for the biomedical research market. The company was founded by Steve Mefferd &. Thomas M. Woerner in 1997 and is headquartered in Owings Mills, MD | Health Technology |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe. | Health Technology |
| Corra Life Sciences, Inc. | |
Accenture LLC
Accenture LLC Miscellaneous Commercial ServicesCommercial Services Accenture LLC operates as a global management consulting, technology services and outsourcing company. The company is headquartered in Reston, VA. | Commercial Services |
Imagia Canexia Health
Imagia Canexia Health Packaged SoftwareTechnology Services Imagia Canexia Health is a genomics-based cancer treatment testing Canadian company that combines AI expertise with advanced molecular biopsy solutions. The private company is located in Canada. The company provides oncologists with AI-based informatics for treatment selection and monitoring, allowing for leading clinical decision support. With a network of over 20 hospitals and reference labs worldwide, they aim to ensure that doctors have the necessary insights to deliver cost-effective cancer testing to patients regardless of where they seek treatment. The CEO of the company is James Lumsdaine. | Technology Services |
Sustained Therapeutics, Inc.
Sustained Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Sustained Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in an undisclosed location. Sustained Therapeutics is developing a sustained-release drug delivery platform for managing acute and chronic pain. The Canadian company is currently conducting clinical trials for ST-01, their innovative sustained-release form of Lidocaine, for various pain indications. Patients can join their trials to experience the benefits of sustained-release Lidocaine today. The company was founded by Martin E. Gleave. | Health Technology |
